Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Oct 4, 2013

Eye on MicroRNA Associations and Signatures

The authors harvested the entire set of publications where microRNAs are mentioned in the title and/or abstract. Find out what they've learned.

Eye on MicroRNA Associations and Signatures

Timelines for publications focusing on microRNAs are among the many features of this incisive report.

  • The focus of this GEN Market & Tech Analysis report is to present some of our recent industry tracking of the microRNA publications ensemble as a means to describe hotspots of microRNA association with biological phenotypes both spatially and temporally.

    We’ve harvested the entire set of publications where microRNAs are mentioned in the title and/or abstract, and this served as the starting material for algorithms to sort them based on their association into specific space. Not only did we generate the hotspot map but also we examined the following:

    • The evolution of the hotspot map over a two-year period
    • Temporal picture, i.e., how the associations “rolled out” over time

    This analysis provides a means for segmenting associations of microRNAs with specific physiological/pathological states and also allows us to examine the “research trends” associated with a given set of microRNAs.

    CLICK HERE to download the PDF report.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »